Watch this welcome video presented by the Honorary Editor-in-Chief Hong-Hao Zhou, MD, PhD. Prof. Zhou briefly introduces the Journal of Xiangya Medicine (JXYM), which is the first English-language medical journal named after Xiangya Hospital and gives his expectation.
Hong-Hao Zhou, member of the Chinese Academy of Engineering, professor of pharmacogenetics, pharmacogenomics and clinical pharmacology in Central South University. He is the Dean of Institute of Clinical Pharmacology at Xiangya Hospital, Central South University; the Director of Training Center and Pilot Unit of Laboratory Testing for Personalized Medicine, National Health and Family Planning Commission.
Professor Zhou is the pioneer and leader of pharmacogenetics research in China. His main contributions are in discovery of the genetic factors in ethnic and interindividual variability in drug response which promoted emphasis on drug management and new drug development around the world, and elucidating the function and mechanism of genetic polymorphisms of drug-metabolism enzymes, transporters and receptors. In 1990s, he has taken the lead in translating scientific findings into tailored personalized medicine in clinical practice and built the first consulting center for personalized medicine and has developed the first genes chip of personalized medicine. Recently, he has been actively promoting the normalization and standardization of the personalized medicine molecular detection in China. He has published more than 430 papers in SCI journals including The New England Journal of Medicine and has been the chief editor of over 10 monographs and textbooks. He has mentored more than 230 master students, PhD students and post-Doctors which become a research and service team for pharmacogenetics and pharmacogenomics.